Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (533) clinical trials

NEUP11-AD2 is a 26 week (plus a 2 week Follow up Visit) double blind study where participants will be randomly assigned (like the flip of a coin) to receive either 1 of 3 doses of study drug (Piromelatine) or a placebo (tablet containing no active ingredients, similar to a sugar ...

Phase

If you qualify, the study may involve 3 screening visits, 1 separate in-clinic stay of 5 days/4 nights and 10 outpatient visits. All study exams and procedures are provided at no cost to you. You do not need medical insurance to participate.

Phase

DAYBREAK-ALZ — the study will last 8 weeks to see if you qualify, plus 3 years of treatment, then 4 weeks of follow-up. The study drug is a tablet, to be taken once a day. The tablet will contain either a lower dose of the study drug, a higher dose ...

Phase

We are conducting free memory screenings in our office for people in the area who are 50 years and older. These memory screens do not require insurance and they will not cost you anything. At Clinical Trials of Texas, Inc. we do conduct multiple memory loss-related studies. If you qualify ...

Phase N/A

Do you or a loved one have concerns about recent memory loss or cognitive decline? Clinical Trials of Texas, Inc. is conducting a long-term observational study in which volunteers can be evaluated and followed to assess their current cognitive state and cognitive function (memory loss) over time. Qualified participants will ...

Phase N/A

A research study is evaluating an investigational medication for mild Alzheimer’s Disease dementia. This research study may be an option for your loved one if: They are 55-85 years of age They have a diagnosis of mild Alzheimer’s Disease dementia All their medication is stable for at least 30 days ...

Phase N/A

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials.

Phase N/A

A 24-month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease (The AMARANTH Study).

Phase N/A